http://www.InteretTherapeutique.org/grossesse/ New studies included in the knowledge base of medication and pregnancy en studies http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Yang et al. Effect of vaginal estrogen supplementation for luteal phase support in the GnRH antagonist protocol on pregnancy outcomes for IVF/ICSI cycles: a randomized controlled trial. Hum Reprod Open 2026; 2026:hoag042http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Martins WP et al. Progestogen-primed ovarian stimulation vs GnRH antagonists and/or agonists for women undergoing assisted reproduction: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2026; 68:188-201-.http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Kriplani et al. Oral dydrogesterone versus oral micronized progesterone: Interim analysis of a randomized controlled trial in pregnant women with threatened miscarriage. Int J Reprod Biomed 2026; 24:605-616http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Kuptarak et al. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial. J Matern Fetal Neonatal Med 2024; 37:2333929http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Kupferminc et al. A prospective randomized trial of human chorionic gonadotrophin or dydrogesterone support following in-vitro fertilization and embryo transfer. Hum Reprod 1990; 5:271-3http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Eftekhar et al. Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT. Int J Reprod Biomed 2019; 17:671-676http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Pabuccu et al. Oral, vaginal or intramuscular progesterone in programmed frozen embryo transfer cycles: a pilot randomized controlled trial. Reprod Biomed Online 2022; 45:1145-1151http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Siew et al. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage. Eur J Obstet Gynecol Reprod Biol 2018; 228:319-324http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Rinaldi et al. Oral dydrogesterone along with vaginal micronized progesterone supplementation for luteal phase support in IVF patients, and its impact on pregnancy and live birth rates: a prospective randomized trial. BMC Pregnancy Childbirth 2024; 24:845http://www.txrating.org/grossesse/viewMA.aspx?exposition=1321Simon et al. Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study. Front Endocrinol (Lausanne) 2022; 13:1039579